Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Axsome Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 348
- −2 vs. Q1 2025
- Shares held
- 37.9M
- +462.6K (+1.2%) vs. Q1 2025
- Total value
- $3.95B
- −$409.9M (−9.4%) vs. Q1 2025
- New holders
- 55
- 154 more added
- Sold out
- 57
- 90 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 505 | $9.34B |
| Q1 2026 | 410 | $6.41B |
| Q4 2025 | 399 | $6.86B |
| Q3 2025 | 355 | $4.51B |
| Q2 2025 | 348 | $3.95B |
| Q1 2025 | 353 | $4.37B |
| Q4 2024 | 292 | $3.15B |
| Q3 2024 | 280 | $3.48B |
| Q2 2024 | 257 | $3.28B |
| Q1 2024 | 259 | $3.09B |
| Q4 2023 | 245 | $3.07B |
| Q3 2023 | 227 | $2.65B |
| Q2 2023 | 231 | $2.61B |
| Q1 2023 | 197 | $1.97B |
| Q4 2022 | 219 | $2.32B |
| Q3 2022 | 188 | $1.15B |
| Q2 2022 | 174 | $826.7M |
| Q1 2022 | 175 | $787.4M |
| Q4 2021 | 167 | $704.2M |
| Q3 2021 | 171 | $627.3M |
| Q2 2021 | 176 | $1.51B |
| Q1 2021 | 184 | $1.31B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Axsome Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Raymond James Financial Inc | 161,412 | $16.8M | 0.01% | +6,337+4.1% | Added |
| Squarepoint Ops LLC | 163,000 | $17.0M | 0.04% | +21,403+15.1% | Added |
| Assenagon Asset Management S.A. | 180,960 | $18.9M | 0.03% | −446,458−71.2% | Reduced |
| MetLife Investment Management | 184,164 | $19.2M | 0.11% | +5,209+2.9% | Added |
| BNP Paribas Arbitrage, SA | 186,437 | $19.5M | 0.02% | +3,805+2.1% | Added |
| JPMorgan Chase & Co | 187,728 | $19.6M | 0.00% | +62,945+50.4% | Added |
| Perceptive Advisors LLC | 198,534 | $20.7M | 0.78% | −156,573−44.1% | Reduced |
| D. E. Shaw & Co., Inc. | 200,764 | $21.0M | 0.02% | −346,901−63.3% | Reduced |
| Bank of New York Mellon Corp | 203,632 | $21.3M | 0.00% | +72,609+55.4% | Added |
| Driehaus Capital Management LLC | 223,280 | $23.3M | 0.19% | +9,141+4.3% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 224,721 | $23.5M | 0.08% | +48,779+27.7% | Added |
| Goldman Sachs Group Inc | 228,204 | $23.8M | 0.00% | −73,514−24.4% | Reduced |
| T. Rowe Price Investment Management, Inc. | 248,726 | $26.0M | 0.02% | −18,271−6.8% | Reduced |
| Loomis Sayles & Co L P | 277,465 | $29.0M | 0.04% | −6,705−2.4% | Reduced |
| Franklin Resources Inc | 278,510 | $29.1M | 0.01% | +51,995+23.0% | Added |
| Nuveen, LLC | 282,971 | $29.5M | 0.01% | −130,170−31.5% | Reduced |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 326,318 | $34.1M | 4.03% | +40,824+14.3% | Added |
| Woodline Partners LP | 331,131 | $34.6M | 0.18% | +27,047+8.9% | Added |
| Point72 Asset Management, L.P. | 350,973 | $36.6M | 0.09% | +224,780+178.1% | Added |
| Principal Financial Group Inc | 355,511 | $37.1M | 0.02% | +59,840+20.2% | Added |
| Charles Schwab Investment Management Inc | 356,651 | $37.2M | 0.01% | +19,405+5.8% | Added |
| Hood River Capital Management LLC | 371,104 | $38.7M | 0.54% | +371,104 | New |
| Qube Research & Technologies Ltd | 391,617 | $40.9M | 0.06% | +109,241+38.7% | Added |
| Northern Trust Corp | 409,394 | $42.7M | 0.01% | −1,575−0.4% | Reduced |
| Pictet Asset Management Holding SA | 411,850 | $43.0M | 0.04% | +78,645+23.6% | Added |
| OrbiMed Advisors LLC | 427,900 | $44.7M | 1.12% | +41,200+10.7% | Added |
| Adage Capital Partners GP, L.L.C. | 447,000 | $46.7M | 0.08% | +399,000+831.3% | Added |
| Morgan Stanley | 447,919 | $46.8M | 0.00% | −9,497−2.1% | Reduced |
| Norges Bank | 468,329 | $48.9M | 0.01% | +30,832+7.0% | Added |
| PFM Health Sciences, LP | 483,105 | $50.4M | 4.37% | −73,440−13.2% | Reduced |
| Man Group plc | 525,069 | $54.8M | 0.12% | +11,848+2.3% | Added |
| Invesco Ltd. | 571,549 | $59.7M | 0.01% | −285,452−33.3% | Reduced |
| UBS Group AG | 595,455 | $62.2M | 0.01% | +306,808+106.3% | Added |
| Price T Rowe Associates Inc | 612,743 | $64.0M | 0.01% | +580,766+1,816.2% | Added |
| Alethea Capital Management, LLC | 667,368 | $69.7M | 52.72% | 00.0% | Unchanged |
| Wellington Management Group LLP | 725,044 | $75.7M | 0.01% | +21,765+3.1% | Added |
| Eventide Asset Management, LLC | 725,672 | $75.7M | 1.33% | −19,178−2.6% | Reduced |
| Bank of America Corp | 753,429 | $78.7M | 0.01% | +219,527+41.1% | Added |
| Deep Track Capital, LP | 801,371 | $83.7M | 2.69% | +801,371 | New |
| Fairmount Funds Management LLC | 815,176 | $85.1M | 11.02% | 00.0% | Unchanged |
| State Street Corp | 958,503 | $100.1M | 0.00% | +52,483+5.8% | Added |
| FMR LLC | 976,730 | $102.0M | 0.01% | −270,501−21.7% | Reduced |
| Geode Capital Management, LLC | 989,453 | $103.3M | 0.01% | +54,600+5.8% | Added |
| Macquarie Group Ltd | 1,137,748 | $118.8M | 0.15% | +161,488+16.5% | Added |
| RTW Investments, LP | 1,516,903 | $158.3M | 2.26% | −1,405,826−48.1% | Reduced |
| BVF Inc | 1,690,221 | $176.4M | 6.30% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,834,990 | $400.3M | 0.01% | +310,579+8.8% | Added |
| Vanguard Group Inc | 3,945,020 | $411.8M | 0.01% | +68,078+1.8% | Added |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −363,200−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −235,383−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −149,600−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −90,141−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −72,113−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −52,683−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −51,199−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −47,005−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −42,222−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −41,922−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −41,200−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −40,866−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −33,280−100.0% | Sold out |
| BCJ Capital Management, LLC | 0 | $0 | 0.00% | −29,544−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −28,998−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −24,431−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −19,615−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −19,112−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −18,038−100.0% | Sold out |
| Phocas Financial Corp. | 0 | $0 | 0.00% | −16,588−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −13,584−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −9,759−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −7,986−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −7,633−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −7,373−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −6,658−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −6,544−100.0% | Sold out |
| Quantitative Investment Management, LLC | 0 | $0 | 0.00% | −5,259−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −3,873−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −3,357−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −3,104−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −3,083−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −3,071−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −2,820−100.0% | Sold out |
| Prosperity Wealth Management, Inc. | 0 | $0 | 0.00% | −2,750−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −2,629−100.0% | Sold out |
| Semanteon Capital Management, LP | 0 | $0 | 0.00% | −2,173−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −2,048−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −1,867−100.0% | Sold out |
| Signature Estate & Investment Advisors LLC | 0 | $0 | 0.00% | −1,832−100.0% | Sold out |
| Bank Hapoalim BM | 0 | $0 | 0.00% | −1,750−100.0% | Sold out |
| Twin Tree Management, LP | 0 | $0 | 0.00% | −997−100.0% | Sold out |
| BI Asset Management Fondsmaeglerselskab A/S | 0 | $0 | 0.00% | −404−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| PSI Advisors, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |